How much funding has C4 Therapeutics raised?

C4 Therapeutics has raised $170.0M in total funding, most recently a Series B round.

Who are C4 Therapeutics's investors?

C4 Therapeutics's investors include Public offering, Bain Capital Life Sciences, Adage Capital, Axil Capital, Commodore Capital.

When was C4 Therapeutics founded?

C4 Therapeutics was founded in 2015.

Where is C4 Therapeutics headquartered?

C4 Therapeutics is headquartered in Watertown, Massachusetts, United States.

What industry is C4 Therapeutics in?

C4 Therapeutics operates in Biotech, Healthcare.

How many employees does C4 Therapeutics have?

C4 Therapeutics has 51-200 employees.

C4 Therapeutics

IPO

Protein Degraded. Disease Targeted. Lives Transformed.

Public · Watertown, United States · Founded 2015 · $170.0M raised

Biotech

Healthcare

Headquarters: Watertown, Massachusetts
Employees: 51–200
Founded: 2015
Business Model: B2B
Website: c4therapeutics.com

Total Funding: $170.0M
Last Round: $170.0M Series BJun 2020
Rounds: 1
Type: Public

About

C4 Therapeutics is a clinical-stage biopharma pioneering targeted protein degradation (TPD). Founded 2015. Lead TPD platform focused on novel target selection.

Summary

C4 Therapeutics is a Biotech company based in Watertown, United States, founded in 2015. It has raised $170.0M in total across 1 round, most recently a $170.0M Series B round in Jun 2020. Investors include Public offering, Bain Capital Life Sciences and Adage Capital.

LinkedIn X (Twitter)